Spine Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial byJosh SandbergSeptember 25, 2024
Spine Top Stories Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain byJosh SandbergSeptember 24, 2024
Spine Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial byJosh SandbergSeptember 10, 2024
Financial Spine Viseon Inc. Completes New Investment Round To Expand Market Opportunities for Its Technologies byJosh SandbergJune 5, 2024
Recon Top Stories First Surgeries Using Stryker’s Infinity With Adaptis and Everlast Successfully Completed in Europe byTim AllenMay 7, 2024
Recon Regulatory Top Stories Lipogems Announces Last Patient Enrolled in the U.S. FDA IDE Arise Study for the Treatment of Knee Osteoarthritis byTim AllenApril 10, 2024
Spine BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease byTim AllenApril 8, 2024
Biologics Financial Top Stories RTI Surgical Completes Acquisition of Cook Biotech byJosh SandbergFebruary 1, 2024
Spine Top Stories 3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023 byJosh SandbergJanuary 10, 2024
